Stage IIIA/B-N2 NSCLC Treatment: Options, Survival Rates & Side Effects Guide

Comprehensive guide to Stage IIIA/B-N2 non-small cell lung cancer treatment: Understand surgery eligibility, chemoradiation, durvalumab immunotherapy, targeted therapy, side effect management, and survival rates. Includes real-world FAQs and case study.